The three most common genetic alterations involved the ARID1A, tp53, and CDKN2A genes.<h4>Conclusions</h4>Advanced CCA displays aggressive clinical behavior, emphasizing the need for treatments beyond chemotherapy. This evidence concerns the gene CDKN2A and cholangiocarcinoma.